metyrapone has been researched along with MS (Multiple Sclerosis) in 3 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miró, J | 1 |
| Amado, JA | 1 |
| Pesquera, C | 1 |
| López-Cordovilla, JJ | 1 |
| Berciano, J | 1 |
| Rinne, UK | 2 |
3 other studies available for metyrapone and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cortodoxone; Female; Humans; Hydrocortisone; Hypotha | 1990 |
Corticotrophin secretion capacity in multiple sclerosis.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acute Disease; Adrenocorticotropic Hormone; Adult; Chron | 1968 |
Corticotrophin secreetion capacity after long-term corticotrophin treatment in multiple sclerosis.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Female; Humans; Long | 1968 |